Corneal collagen cross-linking for infectious keratitis: An update of clinical studies

Acta Ophthalmologica

Volumn 93, Issue 8, 2015, Pages 689-696

  Chan, Tommy C Y ^a,b   Lau, Tiffany W S ^a,b   Lee, Jacky W Y ^c   Wong, Ian Y H ^c   Jhanji, Vishal ^a,b   Wong, Raymond L M ^a,b,c  

^a HONG KONG EYE HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

collagen cross linking; corneal melting; infectious keratitis; photodynamic therapy; riboflavin; ulcer

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFTAZIDIME; ITRACONAZOLE; RIBOFLAVIN; VANCOMYCIN; COLLAGEN; CROSS LINKING REAGENT; PHOTOSENSITIZING AGENT;

ACANTHAMOEBA KERATITIS; BACTERIAL KERATITIS; CLINICAL STUDY; COLLAGEN CROSS LINKING; CORNEA; CORNEA TRANSPLANTATION; CORNEA ULCER; EPITHELIZATION; HERPES SIMPLEX KERATITIS; HUMAN; INFECTIOUS KERATITIS; KERATITIS; KERATOMILEUSIS; KERATOMYCOSIS; KERATOPLASTY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ULTRAVIOLET A RADIATION; BACTERIUM; CORNEA STROMA; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PHOTOCHEMOTHERAPY; ULTRAVIOLET RADIATION;

BACTERIA; COLLAGEN; CORNEAL STROMA; CORNEAL ULCER; CROSS-LINKING REAGENTS; EYE INFECTIONS, BACTERIAL; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 84955732813     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12754     Document Type: Review

References (75)

1. Abbouda A, Abicca I, &, Alio JL, (2014a): Infectious keratitis following corneal crosslinking: a systematic review of reported cases: management, visual outcome, and treatment proposed. Semin Ophthalmol 13: 1-7.
2. Abbouda A, Estrada AV, Rodriguez AE, et al., (2014b): Anterior segment optical coherence tomography in evaluation of severe fungal keratitis infections treated by corneal crosslinking. Eur J Ophthalmol 24: 320-324.
3. Alio JL, Abbouda A, Valle DD, et al., (2013): Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases. J Ophthalmic Inflamm Infect 3: 47.
4. Anwar HM, El-Danasoury AM, &, Hashem AN, (2011): Corneal collagen crosslinking in the treatment of infectious keratitis. Clin Ophthalmol 5: 1277-1280.
5. Arance-Gil A, Gutierrez-Ortega AR, Villa-Collar C, et al., (2014): Corneal cross-linking for Acanthamoeba keratitis in an orthokeratology patient after swimming in contaminated water. Cont Lens Anterior Eye 37: 224-227.
6. Bäckman A, Makdoumi K, Mortensen J, et al., (2014): The efficiency of cross-linking methods in eradication of bacteria is influenced by the riboflavin concentration and the irradiation time of ultraviolet light. Acta Ophthalmol 92: 656-661.
7. Baiocchi S, Mazzotta C, Cerretani D, et al., (2009): Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium. J Cataract Refract Surg 35: 893-899.
8. Bennett HG, Hay J, Kirkness CM, et al., (1998): Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcer. Br J Ophthalmol 82: 137-145.
9. Berra M, Galperin G, Boscaro G, et al., (2013): Treatment of Acanthamoeba keratitis by corneal cross-linking. Cornea 32: 174-178.
10. Bertino JS, (2009): Impact of antibiotic resistance in the management of ocular infection: the role of current and future antibiotics. Clin Ophthalmol 3: 507-521.
11. Bertollo CM, Oliveira AC, Rocha LT, et al., (2006): haracterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models. Eur J Pharmacol 547: 184-191.
12. Bettis DI, Hsu M, &, Moshirfar M, (2012): Corneal collagen cross-linking for nonectatic disorders: a systematic review. J Refract Surg 28: 798-807.
13. del Buey MA, Cristobal JA, Casas P, et al., (2012): Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol 153: 399-404.
14. Caporossi A, Mazzotta C, Paradiso AL, et al., (2013): Transepithelial corneal crosslinking for progressive keratocous: 24-month clinical results. J Cataract Refract Surg 39: 1157-1163.
15. Chan E, Snibson GR, &, Sullivan L, (2014): Treatment of infectious keratitis with riboflavin and ultraviolet-A irradiation. J Cataract Refract Surg 40: 1919-1925.
16. Demirci G, &, Ozdamar A, (2013): A case of medication-resistant Acanthamoeba keratitis treated by corneal crosslinking in Turkey. Case Rep Ophthalmol Med 2013: 608253.
17. Easterbrook PJ, Berlin JA, Gopalan R, et al., (1991): Publication bias in clinical research. Lancet 337: 867-872.
18. Ehlers N, Hjortdal J, Nielsen K, et al., (2009): Riboflavin-UVA treatment in the management of edema and nonhealing ulcers of the cornea. J Refract Surg 25: S803-S806.
19. Ferrari G, Iuliano L, Vigano M, et al., (2013): Impending corneal perforation after collagen cross-linking for herpetic keratitis. J Cataract Refract Surg 39: 638-641.
20. Garduno-Vieyra L, Gonzalez-Sanchez CR, &, Hernandez-Da Mota SE, (2011): Ultraviolet-a light and riboflavin therapy for Acanthamoeba keratitis: a case report. Case Rep Ophthalmol 2: 291-295.
21. Goldrich Y, Marcovich AL, Barkana Y, et al., (2012): Clinical and corneal biomechanical changes after collagen cross-linking with riboflavin and UV irradiation in patients with progressive keratoconus: results after 2 years of follow-up. Cornea 31: 609-614.
22. Goodrich RP, Edrich RA, Li J, et al., (2006): The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 3: 5-17.
23. Hafezi F, Kanellopoulos J, Wiltfang R, et al., (2007): Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg 33: 2035-2040.
24. Iseli HP, Thiel MA, Hafezi F, et al., (2008): Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27: 590-594.
25. Jones DB, (1981): Decision-making in the management of microbial keratitis. Ophthalmology 88: 814-820.
26. Kashiwabuchi RT, Carvalho FR, Khan YA, et al., (2011): Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest Ophthalmol Vis Sci 52: 9333-9338.
27. Kashiwabuchi RT, Carvalho FR, Khan YA, et al., (2013): Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. Graefes Arch Clin Exp Ophthalmol 251: 521-527.
28. Khan YA, Kashiwabuchi RT, Martins SA, et al., (2011): Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118: 324-331.
29. Kozobolis V, Labiris G, Gkika M, et al., (2010): UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea 29: 235-238.
30. Krueger RR, Ramos-Esteban JC, &, Kanellopoulos AJ, (2008): Staged intrastromal delivery of riboflavin with UVA cross-linking in advanced bullous keratopathy: laboratory investigation and first clinical case. J Refract Surg 24: S730-S736.
31. Kumar V, Lockerbie O, Keil SD, et al., (2004): Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 80: 15-21.
32. Kymionis GD, Portaliou DM, Bouzoukis DI, et al., (2007): Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg 33: 1982-1984.
33. Kymionis GD, Karavitaki AE, Kounis GA, et al., (2009a): anagement of pellucid marginal corneal degeneration with simultaneous customized photorefractive keratectomy and collagen crosslinking. J Cataract Refract Surg 35: 1298-1301.
34. Kymionis GD, Kounis GA, Portaliou DM, et al., (2009b): Intraoperative pachymetric measurements during collagen cross-linking with riboflavin and ultraviolet A irradiation. Ophthalmology 116: 2336-2339.
35. Kymionis GD, Kankariya VP, &, Kontadakis GA, (2012): Combined treatment with flap amputation, phototherapeutic keratectomy, and collagen crosslinking in severe intractable post-LASIK atypical mycobacterial infection with corneal melt. J Cataract Refract Surg 38: 713-715.
36. Labiris G, Giarmoukakis A, Larin R, et al., (2014): Corneal collagen cross-linking in a late-onset graft infectious ulcer: a case report. J Med Case Rep 8: 180.
37. Levy SB, (1998): Multidrug resistance: a sign of the times. New Eng J Med 338: 1376-1377.
38. Li Z, Jhanji V, Tao X, et al., (2013): Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol 97: 669-671.
39. Maier P, Bohringer D, &, Reinhard T, (2007): Clear graft survival and immune reactions following emergency keratoplasty. Graefes Arch Clin Exp Ophthalmol 245: 351-359.
40. Makdoumi K, Backman A, Mortensen J, et al., (2010a): Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefes Arch Clin Exp Ophthalmol 248: 207-212.
41. Makdoumi K, Mortensen J, &, Crafoord S, (2010b): Infectious keratitis treated with corneal crosslinking. Cornea 29: 1353-1358.
42. Makdoumi K, Mortensen J, Sorkhabi O, et al., (2012): UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 250: 95-102.
43. Marschner S, &, Goodrich R, (2011): Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother 38: 8-18.
44. Martins SA, Combs JC, Noguera G, et al., (2008): Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Investi Ophthalmol Vis Sci 49: 3402-3408.
45. Mattila JA, Korsbäck A, Krootila K, et al., (2013): Treatment of Pseudomonas aeruginosa keratitis with combined corneal cross-linking and human amniotic membrane transplantation. Acta Ophthalmol 91: 410-411.
46. Micelli Ferrari T, Leozappa M, Lorusso M, et al., (2009): Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report. Eur J Ophthalmol 19: 295-297.
47. Morén H, Malmsjo M, Mortensen J, et al., (2010): Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 29: 102-104.
48. Neu HC, (1992): The crisis in antibiotic resistance. Science 257: 1064-1073.
49. O'Brart DP, (2013): Corneal collagen cross-linking: A review. J Optom 7: 113-124.
50. Panda A, Krishna SN, &, Kumar S, (2012): Photo-activated riboflavin therapy of refractory corneal ulcers. Cornea 31: 1210-1213.
51. Pollhammer M, &, Cursiefen C, (2009): Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg 35: 588-589.
52. Price MO, Tenkman LR, Schrier A, et al., (2012): Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg 28: 706-713.
53. Raiskup-Wolf F, Hoyer A, Spoerl E, et al., (2008): Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg 34: 796-801.
54. Richoz O, Gatzioufas Z, Francois P, et al., (2013): Impact of fluorescein on the antimicrobial efficacy of photoactivated riboflavin in corneal collagen cross-linking. J Refract Surg 29: 842-845.
55. Rosetta P, Vinciguerra R, Romano MR, et al., (2013): Corneal collagen cross-linking window absorption. Cornea 32: 550-554.
56. Ruane PH, Edrich R, Gampp D, et al., (2004): Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 44: 877-885.
57. Russel D, (1999): Radiation sterilization. In:, Russel AG, Hugo WB, &, Ayliffe GAJ, (eds). Principles and practice of disinfection, preservation and sterilization. 3 edn. Oxford, UK: Blackwell Science 67: 5-702.
58. Saglk A, Ucakhan OO, &, Kanpolat A, (2013): Ultraviolet A and riboflavin therapy as an adjunct in corneal ulcer refractory to medical treatment. Eye Contact Lens 39: 413-415.
59. Said DG, Elalfy MS, Gatzioufas Z, et al., (2014): Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology 121: 1377-1382.
60. Sauer A, Letscher-Bru V, Speeg-Schatz C, et al., (2010): In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Investi Ophthalmol Vis Sci 51: 3950-3953.
61. Schrier A, Greebel G, Attia H, et al., (2009): In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J Refract Surg 25: S799-S802.
62. Shetty R, Nagaraja H, Jayadev C, et al., (2014): Collagen crosslinking in the management of advanced non-resolving microbial keratitis. Br J Ophthalmol 98: 1033-1035.
63. Sorkhabi R, Sedgipoor M, &, Mahdavifard A, (2013): Collagen cross-linking for resistant corneal ulcer. Int Ophthalmol 33: 61-66.
64. Spoerl E, Huhle M, &, Seiler T, (1998): nduction of cross-links in corneal tissue. Exp Eye Res 66: 97-103.
65. Spoerl E, Wollensak G, &, Seiler T, (2004): Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 29: 35-40.
66. Tabibian D, Richoz O, Riat A, et al., (2014): Accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis. J Refract Surg 30: 855-857.
67. Tappeiner C, Tschopp m, Schuerch K, et al., (2014): Impact of corneal cross-linking on topical drug penetration in humans. Acta Ophthalmol 92: 656-661.
68. Tayapad JB, Viguilla AQ, &, Reyes JM, (2013): Collagen cross-linking and corneal infections. Curr Opin Ophthalmol 24: 288-290.
69. Tschopp M, Stary J, Frueh BE, et al., (2012): Impact of corneal cross-linking on drug penetration in an ex vivo porcine eye model. Cornea 31: 222-226.
70. Vajpayee RB, Shafi SN, Maharana PK, et al., (2015): Evaluation of corneal collagen cross-linking as an additional therapy in mycotic keratitis. Clin Experiment Ophthalmol 43: 103-107.
71. Wollensak G, &, Iomdina E, (2009): Long-term biomechanical properties of rabbit cornea aftrer photodynamic collagen crosslinking. Acta Ophthalmol 87: 48-51.
72. Wollensak G, Spoerl E, &, Seiler T, (2003): Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135: 620-627.
73. Wollensak G, Aurich H, Wirbelauer C, et al., (2009): Potential use of riboflavin/UVA cross-linking in bullous keratopathy. Ophthalmic Res 41: 114-117.
74. Wong RL, Gangwani RA, Yu LW, et al., (2012): New treatments for bacterial keratitis. J Ophthalmol 2012: 831502.
75. Zamora KV, &, Males JJ, (2009): Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea 28: 474-476.